Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?

With the increasing number of patients affected with metabolic diseases such as type 2 diabetes, obesity, atherosclerosis and insulin resistance, academic researchers and pharmaceutical companies are eager to better understand metabolic syndrome and develop new drugs for its treatment. Many studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Pap, Attila, Cuaranta-Monroy, Ixchelt, Peloquin, Matthew, Nagy, Laszlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000634/
https://www.ncbi.nlm.nih.gov/pubmed/27483259
http://dx.doi.org/10.3390/ijms17081236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5000634/
https://www.ncbi.nlm.nih.gov/pubmed/27483259
http://dx.doi.org/10.3390/ijms17081236

Ejemplares similares